That is not good logic. I pointed this out previously -- consider if there were only 100 Nrx a week and each one required a refill every three months -- this is over simplifying but it's just meant to get the point across:
1st quarter per week nrx -- 100, refills zero
2nd qtr -- 100 nrx per week plus refills increase steadily to -- at best -- 100 per week from the 1st qtr nrx running out
3rd qtr -- 100 nrx/wk, now refills increase to 200 from the 2nd quarter running out and the first quarter running out AGAIN
4th qtr -- 100 nrx/wk, ditto as refills increase to 300 from the first 3 quarters scripts running out
Etc, etc. Get it? Even if Nrx = 100 per week,if diabetics were actually using the drug as their regular meal insulin, by now, refills would be probably in the many hundreds or even thousands.
But no, they're still lingering at less than 250 despite somewhere north of 40,000 Nrxs having been written dince launch!
That means that practically no one is using afrezza as their regular prandial. They are either discounting its use or else using it only occasionally for convenience or spot episodes of hyperglycemia.
Even "afrezzauser" himself tweeted that refill numbers are "HORRIFIC" and that he doesn't understand why no one seems to be coming back to the drug after trying it. But the explanation is simple -- it simply doesn't work as well as the RAAs the diabetics usually use.
